Results 151 to 160 of about 758,896 (346)
Abstract Introduction Active surveillance of adverse events using healthcare data is emerging as complementary to the monitoring of spontaneous reports and stand‐alone pharmacoepidemiologic studies. The risk of urinary tract infections (UTIs) was listed as a special warning for sodium‐glucose cotransporter‐2 inhibitors (SGLT2is) when marketed in Europe
Haoxin Le +5 more
wiley +1 more source
Aim Novel oral polio vaccine type 2 (nOPV2) was used under the WHO emergency use listing for circulating vaccine‐derived polio virus (cVDPV) outbreaks from 2021 to 2023. We assessed nOPV2 adverse events following immunization (AEFIs) and compared its safety profile to other vaccines using VigiBase.
Comfort Kunak Ogar +6 more
wiley +1 more source
Correlation between rectal diameter and constipation with urinary tract infections in children
Background and Objective: Urinary tract infection is the second common bacterial infection in children. Constipation as a risk factor in urinary tract infection was reported by several studies.
Alaee AR +3 more
doaj
Fiber‐type soft bioelectronics for wearable and implantable sensing and therapy
Fiber‐type soft bioelectronics are emerging as versatile platforms for wearable and implantable health monitoring and therapeutic applications. These bioelectronics use organic and inorganic matrices combined with advanced fillers, which feature high conductivity, electrochemical sensitivity, softness, and biocompatibility.
Haneul Kim +5 more
wiley +1 more source
Lower urinary tract dysfunction is clinically important because it may cause urinary tract infections, mainly due to accumulation of residual urine, and adversely affect renal function.
Matjaž Kopač
doaj +1 more source
Nanomaterial‐based immune therapeutic strategies in neurodegenerative diseases
This review highlights the immunomodulatory potential of nanomaterials (NMs) in treating neurodegenerative diseases (NDs). It focuses on their roles in regulating innate and adaptive immune responses to maintain immune homeostasis. By providing insights into these mechanisms, the review lays the groundwork for innovative NMs therapeutic strategies to ...
Xinru Zhou +6 more
wiley +1 more source
Use of cephaloridine in urinary tract infections [PDF]
Thirty-one patients with various urinary tract infec t ions were treated with Cephaloridine. A single dose of 500 mg was administered intramusculary for five to nine days and its results were evaluated. In seven cases of acute cystitis, Cephaloridine was
依田, 丞司 +4 more
core
Target trial emulation of a multi‐institutional electronic health record network showed comparable cardiorenal effectiveness and safety of dapagliflozin versus empagliflozin in adults with type 2 diabetes and advanced‐stage chronic kidney disease.
Shih‐Hsuan Lin +6 more
wiley +1 more source
Urinary tract infections: epidemiological and clinical aspects
Urinary tract infections are one of the most common infections affecting outpatients and hospital patients. They are believed to affect 150 million people annually and can present as an asymptomatic infection or infections of varying course and location.
Zuzanna Trześniewska-Ofiara +2 more
doaj +1 more source
Complicated urinary tract infections
No standard definition exists for the term, complicated urinary tract infection. The term is usually used to convey an infection that occurs in a host with altered defenses or in a patient with a structural or functional abnormality impeding urine flow.
openaire +2 more sources

